Neovascular Glaucoma — Clinical Trials

MONDO:00197834 active·1 recruitingLast updated: Mar 19, 2026, 12:58 PM

Trial Landscape

Neovascular Glaucoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure2

By Phase

Phase 1

3 trials are observational or have no phase designation.

Sponsor Types

Academic/Other3Industry1

Top Sponsors

Bayer

Trial Locations

China2 trials

Iran1 trial

Japan1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

4 Trials

Recruiting

NCT04519619

Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

Sponsor:Bayer

JapanStarted: Nov 2020Est. completion: Jun 2028Updated: Mar 2026

Phase 1Active, Not Recruiting

NCT04844619

KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial

Sponsor:Sun Yat-sen University

ChinaStarted: Apr 2021Est. completion: Dec 2024Updated: Dec 2024

Not ApplicableActive, Not Recruiting

NCT07201415

Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma

Sponsor:Zhongnan Hospital

ChinaStarted: Jan 2025Est. completion: Mar 2027Updated: Oct 2025

Not ApplicableActive, Not Recruiting

NCT05316142

Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma

Sponsor:Iran University of Medical Sciences

IranStarted: May 2024Est. completion: Dec 2025Updated: May 2025

Stay informed about clinical trials for Neovascular Glaucoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 12:58 PM